Skip to main content
. 2006 May 18;103(22):8493–8498. doi: 10.1073/pnas.0509821103

Table 1.

Summary of phenotypic properties of VSV L gene mutants

Mutant Plaque size, mm Titer, 24 h, log10 pfu/ml RNA synthesis
Protein 7mG% [AdoMet]
GpppAm, %
Cells In vitro 1 mM 0.2 mM
rVSV 4.1 ± 0.5* 9.7 ± 0.2 100 100 100 97 94 2
G1670A 2.8 ± 0.4 8.8 ± 0.1 108 90 80 20 <1 75
G1672A 2.2 ± 0.3 8.7 ± 0.2 110 100 90 10 <1 80
G1674A 4.2 ± 0.6* 9.8 ± 0.1 110 110 105 92 36 5
G1675A 1.5 ± 0.3 7.5 ± 0.2 50–250§ 50 75 15 <1 <1
G4A 1.4 ± 0.3 6.1 ± 0.4 55–350§ 40 55–110 <1 <1 <1
D1735A 3.0 ± 0.4 8.6 ± 0.2 70 55 40–90 30 10 15
D1671V 1.8 ± 0.3 6.8 ± 0.1 70 75 85 <1 <1 <1
S1673A 3.1 ± 0.4 8.4 ± 0.1 70 60 35–90 20 10 75
G4AD 1.6 ± 0.3 6.4 ± 0.1 75–370§ 35 80–110 <1 <1 <1

pfu, plaque-forming units.

*Plaque diameter was measured at 24 h after inoculation.

Plaque diameter was measured at 48 h after inoculation.

Plaque diameter was measured at 96 h after inoculation.

§Percentage of RNA varied as follows: P/M (50%)-V (250%); P/M (55%)-V (350%); P/M (75%)-V (370%).

Percentage of protein varied as follows: L (55%)-N (110%); L (40%)-N (90%); L (35%)-N (90%); L (80%)-N (110%).